Hikma Pharmaceutical | HIK - Selling And Administration Expenses

Stock Price
1,229.00
Daily Change
-11.00 -0.89%
Monthly
-23.19%
Yearly
-39.46%
Q1 Forecast
1,214.21

Hikma Pharmaceutical reported $288M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
argenx SE USD 429.62M 93.32M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Autolus Therapeutics Ltd USD 34.11M 6.16M Sep/2025
Bayer EUR 4.05B 647M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Orion EUR 110.7M 26.1M Dec/2025
Recordati EUR 171.38M 15.6M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
UCB EUR 1.29B 221M Dec/2024